The year 1995-1996 in review: Genetically re-engineering clinical nephrology

Pediatric Nephrology

Volumn 11, Issue 3, 1997, Pages 377-381

  Trachtman, Howard ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

Bartter's syndrome; Chronic renal failure; Enuresis; Genetics; Gitelman's syndrome; Hemolytic uremic syndrome; IgA nephropathy

Indexed keywords

ARTICLE; BARTTER SYNDROME; CHRONIC KIDNEY FAILURE; ENURESIS; GITELMAN SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; MEDICAL GENETICS; NEPHROLOGY; PRIORITY JOURNAL; RISK FACTOR;

CHILD; GENE THERAPY; GENETIC ENGINEERING; HUMANS; KIDNEY DISEASES; NEPHROLOGY;

EID: 0030943517     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050302     Document Type: Article

References (27)

1. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC (1962) Hyperplasia of the juxtamedullary complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 33: 811-828
2. Roy S III, Arant BS Jr (1981) Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency. Pediatrics 67: 423-429
3. Stein JH (1985) The pathogenetic spectrum of Bartter's syndrome. Kidney Int 28: 85-93
4. Gitelman HJ, Graham JB, Welt LG (1966) A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79: 221-235
5. Bettinelli A, Bianchetti MG, Girardin E, Caringella A, Cecconi M, Appiani AC, Pavanello L, Gastaldi R, Isimbaldi C, Lama G, Marchesoni C, Matteucci C, Patriarca P, DiNatale B, Setzu C, Vituci P (1992) Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120: 38-43
6. Gitelman HJ (1992) Hypokalemia, hypomagnesemia, and alkalosis: a rose is a rose - or is it? J Pediatr 120: 79-80
7. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP (1996) Giteiman's variant of Banter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genet 12: 24-30
8. Karolyi L, Ziegler A, Pollak M, Fishbach M, Grzeschik KH, Koch MC. Seyberth HW (1996) Giteiman's syndrome is genetically distinct from other forms of Bartter's syndrome. Pediatr Nephrol 10: 551-554
9. + channel, ROMK Nature Genet 14: 152-156
10. Rittig S, Knudsen UB, Norgaard JP, Pederson EB, Djurhuus JC (1989) Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256: F664-F671
11. Klauber GT (1989) Clinical efficacy and safety of desmopressin in the treatment of nocturnal enuresis. J Pediatr 114: 719-722
12. Eiberg H, Berendt I, Mohr J (1995) Assignment of dominant inherited nocturnal enuresis (ENUR1) to chromosome 13q. Nature Genet 10: 354-356
13. Galla JH (1995) IgA nephropathy. Kidney Int 47: 377-387
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P. Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
15. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O (1995) Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169
16. Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon VI(1996) Angiotensin convening enzyme gene polymorphism, potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49: 571-577
17. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH. Riegger GAJ (1994) Association between a deletion polymorphism of die angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330: 1634-1638
18. Lindpainter K, Lee M, Larson MG, Rao S, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PWF, Vasan RS. Myers RH, Levy D (1996) Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334: 1023-1028
19. Woo D (1995) Apoptosis and loss of renal tissue in polycystic dney diseases. N Engl J Med 333: 18-25
20. Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon RA, Woolf AS (1996) Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49: 135-146
21. Fick GM. Gabow PA (1994) Hereditary and acquired cystic disease of the kidney. Kidney Int 46: 951-964
22. Klahr S, Schreiner G. Ichikawa I (1988) The progression of renal disease. N Engl J Med 318: 1657-1666
23. Brenner BM, Chertow GM (1994) Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23: 171-175
24. Zalups RK (1993) The Os/+ mouse: a genetic animal model of reduced renal mass. Am J Physiol 264: F53-F60
25. He CJ, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker LJ (1996) Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. Clin Invest 97: 1242-1249
26. Ludwig K, Ruder H, Rott HD, Karch H (1996) Outcome of an enterohemorrhagic Escherichia coll O157 infection in monozygotic twins. Lancet 347: 196-197
27. Hubbard R, Lewontin RC (1996) Pitfalls of genetic testing. N Engl J Med 334: 1192-1194